No profile data available.
Sanofi (SNY) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Paris, France, with about 74,846 full-time employees.
It reported revenue of 46.72 billion EUR for fiscal year 2025, up 5.5% from fiscal year 2024, and net income of 7.81 billion EUR. In Q2 2026 (the quarter ended June 30, 2026) revenue was 12.30 billion EUR, up 14.6% from a year before. Its largest business segment, Biopharma, brought in 99% of segment revenue in fiscal year 2025; United States was the largest region with 51%. Its market capitalization was $96.01 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines.
Sanofi reported 46.72 billion EUR in revenue for fiscal year 2025, up 5.5% from 44.29 billion EUR in fiscal year 2024. In Q2 2026 revenue was 12.30 billion EUR.
Biopharma, with 46.23 billion EUR or 99% of segment revenue in fiscal year 2025. Next: Others (1%).
United States: 51% of revenue by region in fiscal year 2025, followed by Rest of The World (22%).
$96.01 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include AstraZeneca PLC (AZN), Amgen Inc. (AMGN), Pfizer Inc. (PFE), GSK plc (GSK).